The U.S. Food & Drug Administration (FDA) has granted clearance to initiate a Phase I/II clinical trial evaluating Alpha-1 Antitrypsin (AAT) in type 1 diabetics, based on research by BGU's Dr. Eli Lewis. more »
BGU scientists cured diabetes in a mouse by supplying healthy cells that enabled its immune system to continue to function, creating the closest cure for diabetes to date. more »
BGU's Dr. Eli Lewis discusses his breakthrough research in type 1 diabetes and islet transplantation therapy. more »
Studying the Development of DiabetesResearch by BGU Prof. Angel Porgador shows there is no strong genetic connection to type 1 diabetes. more » |
Blazing New Trails in Diabetes ResearchNathan de Felice, a student from BGU’s Medical School for International Health, who also has diabetes himself, talks about working toward a cure. more » |
Breakthrough Diabetes Research from IsraelDr. Eli Lewis talks with Israel21C about his research into a novel method for transplanting healthy insulin-producing cells into a diabetic's pancreas. more » |
BGU's Groundbreaking Diabetes ResearchDr. Eli Lewis talks about the success of the FDA-approved clinical trials now under way at University of Colorado, Harvard University and in Israel for individuals with type 1 diabetes. more » |